Yahoo
NasdaqGS - Delayed Quote USD

C4 Therapeutics, Inc. (CCCC)

3.7600 +0.0200 (+0.53%)
At close: September 4 at 4:00:01 PM EDT
3.7232 -0.0368 (-0.98%)
After hours: September 4 at 7:30:03 PM EDT
Trade CCCC on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
35,039
35,947
35,584
20,756
31,096
Operating Expense
136,071
140,436
152,761
159,787
160,630
Operating Income
-101,032
-104,489
-117,177
-139,031
-129,534
Net Non Operating Interest Income Expense
10,470
10,349
14,429
8,439
1,359
Other Income Expense
--
-10,733
-2,437
-621
--
Pretax Income
-101,295
-104,873
-105,185
-131,213
-128,175
Tax Provision
--
121
131
1,280
0
Net Income Common Stockholders
-101,416
-104,994
-105,316
-132,493
-128,175
Diluted NI Available to Com Stockholders
-101,416
-104,994
-105,316
-132,493
-128,175
Basic EPS
-0.91
-1.27
-1.52
-2.67
-2.62
Diluted EPS
-0.91
-1.27
-1.52
-2.67
-2.62
Basic Average Shares
111,633.7320
82,894.4590
69,372.9930
49,640.5050
48,861.6650
Diluted Average Shares
111,633.7320
82,894.4590
69,372.9930
49,640.5050
48,861.6650
Total Operating Income as Reported
-111,765
-115,222
-119,614
-139,031
-129,534
Total Expenses
136,071
140,436
152,761
159,787
160,630
Net Income from Continuing & Discontinued Operation
-101,416
-104,994
-105,316
-132,493
-128,175
Normalized Income
-90,683
-96,514.9300
-103,390.7700
-132,002.4100
-128,175
Interest Income
10,470
10,349
14,429
9,812
3,575
Interest Expense
--
--
0
1,373
2,216
Net Interest Income
10,470
10,349
14,429
8,439
1,359
EBIT
-101,032
-104,489
-117,177
-129,840
-125,959
EBITDA
-99,448
-102,530
-115,359
-127,960
-124,283
Reconciled Depreciation
1,584
1,959
1,818
1,880
1,676
Net Income from Continuing Operation Net Minority Interest
-101,416
-104,994
-105,316
-132,493
-128,175
Total Unusual Items Excluding Goodwill
-10,733
-10,733
-2,437
-621
0
Total Unusual Items
-10,733
-10,733
-2,437
-621
0
Normalized EBITDA
-88,715
-91,797
-112,922
-127,339
-124,283
Tax Rate for Calcs
0
0.0002
0.0002
0.0002
0
Tax Effect of Unusual Items
0
-2,253.9300
-511.7700
-130.4100
0
12/31/2022 - 10/2/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: